SureTrader Advertisement SureTrader
Home > Boards > Free Zone > Health and Sciences > Biotech Values

Normally I'd agree - but on 3yr paper

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
10nisman Member Profile
 
Followed By 6
Posts 1,553
Boards Moderated 0
Alias Born 10/26/03
160x600 placeholder
Wall Street Selloff Fueled By Sinking Energy, Financials Stocks
Dow drops triple-digits; Vix jumps U.S. stocks sold off sharply Tuesday, with the Dow industrials dropping 170 points, as...
Top Equities Stories Of The Day
Pinterest Acquires Mobile Ad Firm URX
Deutsche Bank North America CEO Jacques Brand to Leave for PJT Partners
Ackman: No Plans to Sell Any Valeant `Crown Jewel' Assets -CNBC
Halliburton's Loss Deepens--2nd Update
Fiat Chrysler's U.S. Auto Sales Rise
Brazilian Judge Puts Temporary Ban on WhatsApp -- Update
Abbott to Acquire St. Jude -- WSJ
U.S. Auto Sales Back on Track in April--3rd Update
10nisman   Thursday, 09/23/10 12:08:13 PM
Re: wallstarb post# 104887
Post # of 201119 
Quote:
Normally I'd agree - but on 3yr paper it doesnt have the duration for a longer term investment, and unless MSFT is buying junk bonds with it I really dont see the point for them. Perhaps an acquisition on the horizon - or maybe they are buying some CMOs

The vast majority of MSFT's cash is overseas and thus to get around paying taxes to repatriate it they chose to issue debt at insanely attractive levels. MSFT will likely use the cash to pay its dividend and buy-back shares.

10nis

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist